Bottom line
Is GMRAX a good fund? The bottom line
GMRAX is the Class A share class of Nationwide Small Cap Index Fund, an index small-cap mutual fund from Nationwide.
It charges 0.67% — about $67 a year on every $10,000 invested, cheaper than 83% of small-cap funds we track.
It returned +5.8% over one year, +4.3% a year over five years, +8.4% a year over ten (as of Dec 31, 2025, per its prospectus).
With $274 million in net assets and 1,959 holdings, its largest position is Cf Secured Llc (6.3%) and the top 10 make up 10% of the portfolio.
This share class carries a front-end sales charge of up to 5.75%; a no-load class or ETF alternative can avoid it.
What stands out
- Low cost: cheaper than 83% of small-cap peers
- Broadly diversified (1,959 holdings)
What to watch
- 5-year return in the bottom quarter of its category
- Front-end sales load up to 5.75%
- 12b-1 marketing fee of 0.25% a year
Updated Nov 19, 2026
What GMRAX invests in
The Nationwide Small Cap Index Fund seeks to match the performance of the Russell 2000 Index (Russell 2000 Index) as closely as possible before the deduction of Fund expenses.
The Fund employs a passive management, or indexing, approach, which seeks to match approximately the performance of the Russell 2000 Index before the deduction of Fund expenses. The Russell 2000 Index is composed of equity securities of approximately 2,000 small-cap U.S. companies in a wide range of businesses. To the extent that the Russell 2000 Index emphasizes certain sectors, the Fund will likely similarly emphasize any such sectors. Under normal circumstances, the Fund invests at least 80% of its net assets in a statistically selected sampling of securities of companies included in the Russell 2000 Index. The Fund does not necessarily invest in all of the securities included in the Russell 2000 Index or in the same weightings. The Fund intends to be diversified in approximately the same proportion as the Russell 2000 Index is diversified. The Fund may become nondiversified, as…
From the fund's prospectus (filed Feb 19, 2026).
GMRAX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| GMRAX | +5.8% | +4.3% | +8.4% |
| Small-Cap median | +7.6% | +7.0% | +9.2% |
Source: Fund prospectus, as of Dec 31, 2025
What GMRAX costs
On a $10,000 investment, GMRAX's 0.67% expense ratio costs about $67 a year. The prospectus estimates $1,414 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.
GMRAX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Cf Secured Llc | 6.32% |
| 2 | Santander US Capital Markets Llc | 1.10% |
| 3 | Moog, Inc. | 0.36% |
| 4 | Hut 8 Corp. | 0.35% |
| 5 | UMB Financial Corp. | 0.34% |
| 6 | Cytokinetics, Inc. | 0.32% |
| 7 | Viasat, Inc. | 0.31% |
| 8 | BrightSpring Health Services, Inc. | 0.31% |
| 9 | Glaukos Corp. | 0.31% |
| 10 | CareTrust REIT, Inc. | 0.30% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 10% of the fund. See all top 25 holdings and asset mix →